In a drastic attempt to lower costs and boost profitability, embattled multi-state marijuana company MedMen will lay off 190 employees and sell its stake in a cannabis real estate investment trust (REIT), among other right-sizing maneuvers.
In early August, some of the first cases of vaping-related lung injuries, known as EVALI, began to surface. Fast forward three months, and more than 2,000 EVALI cases have since been documented by the Centers for Disease Control and Prevention, which is pointing to vitamin E acetate as a leading culprit. So where does the cannabis industry go from here?
In this week’s edition of The Buzz: Vitamin E acetate is identified as the likely culprit in the vaping crisis, California regulators suspend nearly 400 licenses, Canopy Growth Corporation teams up with Canadian rapper Drake, and Bruce Linton lands at Vireo Health International.
The restaurateurs behind Frankies Spuntino Group and the Oro di Sicilia olive oil line recently teamed up with Canadian cannabis entrepreneur and financier Paul Rosen to launch Pantry, a cannabis-infused food company that makes low-dose edibles.
American financial institutions could be waiting for the U.S. Senate to pass its version of the Secure and Fair Enforcement (SAFE) Banking Act of 2019 before offering services to more cannabis businesses, recent federal data indicates.
The global cannabis market is poised to be worth $41 billion by 2024, BDS Analytics shared during the 2019 Cannabis World Congress & Business Exposition in Boston. However, Brightfield Group has a slightly more modest outlook. The Chicago-based firm estimates that U.S. cannabis sales will reach $23 billion 2023.
Kiva Brands, one of the most recognizable THC-infused food companies in California, is fresh off a $12.3 million capital infusion that it hopes will boost innovation and help solidify its position as a leader in the edibles category.
Hundreds of New England-based cannabis industry professionals turned out for the 3rd annual Cannabis World Congress & Business Exposition (CWCB Expo), held last week at the Hynes Convention Center in Boston. In addition to connecting with suppliers and CBD brands, attendees heard from a number of industry stakeholders across several seminar sessions.
Two-thirds of Americans still support federal legalization of cannabis according to a new Gallup survey released on Wednesday. The analytics and polling firm shared the results of its annual crime survey, which was conducted in early October and found that 66% of U.S. adults were in favor of legalizing cannabis.